Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.840
-0.150 (-3.76%)
At close: Nov 16, 2026, 4:00 PM EST
3.925
+0.085 (2.20%)
After-hours: Nov 16, 2026, 7:59 PM EST

Nuvation Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
201.7362.97.87---
Revenue Growth
654.19%698.96%----
Gross Profit
173.0653.60.8---
Operating Income
-123.4-213.06-167.56-99.82-119.73-89.53
Net Income
-135.93-204.63-567.94-75.8-104.2-86.85
Earnings Per Share
-0.39-0.60-2.11-0.35-0.48-0.44
EPS Growth
------

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024
Period EndingSep '26 Dec '25 Dec '24
United States
143.7424.66-
China
29.749.415.15
Japan
28.2428.832.73
Total
201.7362.97.87

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
663.37529.21502.69611.21661.01765.39
Total Debt
468.1366.948.924.014.263.06
Net Cash (Debt)
195.25462.27493.78607.21656.75762.34
Net Cash Growth
-42.73%-6.38%-18.68%-7.54%-13.85%253.34%
Net Cash Per Share
0.561.351.842.773.033.85

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-106.19-173.43-130.41-68-96.11-68.19
Capital Expenditures
-1.98-0.35-0.16-0.07-0.37-0.28
Free Cash Flow
-108.17-173.78-130.58-68.07-96.48-68.47
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
85.79%85.22%10.10%---
Operating Margin
-61.17%-338.72%-2128.25%---
Pretax Margin
-67.38%-325.31%-7213.76%---
Profit Margin
-67.38%-325.31%-7213.76%---
FCF Margin
-53.62%-276.27%-1658.52%---

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.7548.83113.71---